Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets.

Genome medicine - 7 Jan 2021

Ward Daniel, Higgins Matthew, Phelan Jody E, Hibberd Martin L, Campino Susana, Clark Taane G

Abstract excerpt

During COVID-19, diagnostic serological tools and vaccines have been developed. To inform control activities in a post-vaccine surveillance setting, we have developed an online "immuno-analytics" resource that combines epitope, sequence, protein and SARS-CoV-2 mutation analysis. SARS-CoV-2 spike and nucleocapsid proteins are both vaccine and serological diagnostic targets. Using the tool, the nucleocapsid protein...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coronavirus Nucleocapsid Proteins
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Testing

Share to COVID-19 Vaccines

Share to Epitopes, B-Lymphocyte

Share to Histocompatibility Antigens Class I

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 33413610
DOI: 10.1186/s13073-020-00822-6
PMCID: PMC7790334

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets.PMID 33413610Read ↗

An integrated <i>in silico</i> immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targetsSemantic proximity Read ↗

Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches.Semantic proximity Read ↗

Design of a Companion Bioinformatic Tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variantsSemantic proximity Read ↗

Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants.Semantic proximity Read ↗

Exploring B-cell epitope conservation and antigenicity shift in current COVID-19 variants: Analyzing spike-antibody interactions for therapeutic uses.Semantic proximity Read ↗

Algorithm for the Quantitation of Variants of Concern for Rationally Designed Vaccines Based on the Isolation of SARS-CoV-2 Hawaiʻi Lineage B.1.243Semantic proximity Read ↗

Immunoinformatics Patterns and Characteristic of Epitope-Based Peptide Vaccine candidates against COVID-19Semantic proximity Read ↗

Enhancing Diagnostic Sensitivity: Investigating Molecular Mechanisms of Antigen Rapid Diagnostic Test (AgRDTs) Variability Across SARS-CoV-2 VariantsSemantic proximity Read ↗

Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine TargetsSemantic proximity Read ↗

In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19Semantic proximity Read ↗

Analysis of the full genome sequences of SARS-CoV-2 isolates to determine antigenic proteins and epitopes to be used for the development of a vaccine or a diagnostic approach for COVID-19Semantic proximity Read ↗

In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.